Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

mike_maclean

PureTech appoints Michael MacLean as chief financial officer

September 14, 2015 Medical Communications, Research and Development, Sales and Marketing Michael MacLean, PureTech Health

PureTech Health has appointed Michael MacLean to the management team, as chief financial officer and executive vice president. Michael MacLean …
Appointment
fda_building

FDA strengthens safety warning for J&J’s diabetes drug Invokana

September 14, 2015 Sales and Marketing FDA, Food and Drugs Administration, Invokamet, J&J, JJ, Johnson & Johnson, diabetes, invokana, safety warning, type 2 diabetes

Johnson & Johnson has suffered a blow after the FDA strengthened its safety warning for the company’s type 2 diabetes …
News
janssen_stairs

Janssen submits EMA application for myeloma drug

September 14, 2015 Sales and Marketing Janssen, daratumumab, multiple myeloma

Janssen has submitted a new marketing authorisation application for European approval of daratumumab for the treatment of patients with relapsed …
News
ofev1

Boehringer earns NICE nod for IPF drug Ofev

September 14, 2015 Sales and Marketing Boehringer Ingelheim, IPF, NICE, idiopathic pulmonary fibrosis

NICE has recommended Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis after the German firm agreed to a …
News
zs-pharma-logo_cmyk

Actelion confirms takeover talks with ZS Pharma

September 11, 2015 Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …
News
lyrica

High Court rules against Pfizer in Lyrica patent case

September 10, 2015 Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …
News
heart_rate_monitor_app

Featured market report: Healthcare mobility solutions market by products and services, global forecast to 2020

September 10, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing apps, healthcare mobility, market report, mobile healthcare, smartphones

The global healthcare mobility solutions market is set to grow by as much as 30% to 2020, as the healthcare …
Feature
lung cancer x ray

Lung cancer market to hit $10.9bn by 2021

September 10, 2015 Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer

The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …
News
Mylan building

Mylan to relaunch $27.1bn hostile takeover of Perrigo

September 10, 2015 Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover

Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …
News
avastin

New treatment option for ovarian cancer patients in Scotland

September 8, 2015 Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …
News
ABPI image

ABPI ‘deeply concerned’ by slow UK drugs uptake

September 7, 2015 Sales and Marketing ABPI, PPRS, Pharmaceutical Price Regulation Scheme, drugs bill, market access, medicines bill

The UK pharma industry paid £209 million to underwrite the UK medicines bill in second quarter of 2015, according to …
News
keytruda

NICE recommends Keytruda for advanced skin cancer

September 7, 2015 Research and Development, Sales and Marketing Merck, NICE, keytruda, skin cancer

NICE has approved Merck’s Keytruda (pembrolizumab) as a treatment for advanced skin cancer in final draft guidance for the NHS.  …
News
healthcareusnow

Pharma industry to deliver strong growth – despite price pressure

September 7, 2015 Sales and Marketing Moody's, financial ratings, industry, industry growth, pharma, pharma industry

The global pharma industry will buck the trend of growing pricing pressure and deliver strong growth in profits, according to a …
News
neuron

Neurology comes to the fore

September 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alzheimer's disease, multiple sclerosis, neurology

Neurology is an area where pharma has struggled to deliver in recent years.Yet the high unmet need for drugs to …
Feature
revlimid_celgene

Celgene threatens to scale back UK clinical trial investment after CDF snub

September 4, 2015 Research and Development, Sales and Marketing Cancer, Cancer Drugs Fund, Celgene, Revlimid, british nhs

One of the world’s leading pharma companies in oncology is considering whether to continue investing in clinical trials in the …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026